According to MaxCyte's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.30. At the end of 2024 the company had a P/S ratio of 11.4.
Year | P/S ratio | Change |
---|---|---|
2024 | 11.4 | -3.42% |
2023 | 11.8 | -6.34% |
2022 | 12.6 | -58.63% |
2021 | 30.4 |